English 
Dutch 
French 
Increasing numbers of customers in biology, drug discovery, food and cosmetics have witnessed the clear benefits of microfluidic flow processes, including droplet manufacture, compared with conventional batch methods such as increased yield and purity.
The drawback to adoption in pilot scale and industrial settings was the lack of a scale up method. This created a need for a scale-up platform powered by the same microfluidic technology that had successfully proved itself for low throughput, including droplet manufacture.
The common customer requirements were:
- Up to 3 ml/min emulsion per Telos Chip
- 30 to 400 ml of Droplets
- 30 µm to 200 µm Droplet Diameter
- Versatile Particle Material
- Reusable
- Reconfigurable
- Directly Scalable
